Sökning: WFRF:(Lilja Mikael) >
Partial clinical re...
Partial clinical remission of Type 1 diabetes in Swedish children : A longitudinal study from the Swedish National Quality Register (SWEDIABKIDS) and the Better Diabetes Diagnosis (BDD) study
-
- Fureman, Anna-Lena (författare)
- Umeå universitet,Pediatrik,Umea Univ, Sweden
-
- Bladh, Marie (författare)
- Linköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, Kvinnokliniken US
-
- Carlsson, Annelie (författare)
- Department of Clinical Sciences, Lund, Lund University, Skånes University Hospital, Lund, Sweden,Lund Univ, Sweden
-
visa fler...
-
- Forsander, Gun, 1951 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,Sahlgrens Univ Hosp, Sweden; Univ Gothenburg, Sweden
-
- Lilja, Mikael (författare)
- Umeå universitet,Institutionen för folkhälsa och klinisk medicin,Umea Univ, Sweden
-
- Ludvigsson, Johnny (författare)
- Linköping University, Linköping, Östergötland, Sweden,Crown Princess Victoria Children’s Hospital, Division of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden,Umea Univ, Sweden
-
- Samuelsson, Ulf (författare)
- Linköping University, Linköping, Östergötland, Sweden,Crown Princess Victoria Children’s Hospital, Division of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden,Umea Univ, Sweden
-
- Särnblad, Stefan, 1963- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Department of Pediatrics, University Hospital Örebro, Örebro, Sweden,Orebro Univ, Sweden; Univ Hosp Orebro, Sweden
-
- Lind, Torbjörn, 1966- (författare)
- Umeå universitet,Pediatrik,Umea Univ, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2024
- 2024
- Engelska.
-
Ingår i: Diabetes Technology & Therapeutics. - : Mary Ann Liebert. - 1520-9156 .- 1557-8593.
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://gup.ub.gu.se...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- AIMS/HYPOTHESIS: To investigate the frequency and characteristics of partial remission in Swedish children with type 1 diabetes and whether insulin delivery method, i.e., continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI) affect incidence and duration of this period 2007-2011. Factors that increase the proportion of subjects that enter partial remission and extend this period can improve long-term metabolic control and reduce the risk of severe hypoglycemia, improve quality of life and in the long run reduce late complications.METHODS: Longitudinal data from 2007-2020 were extracted from the Swedish National Quality Register (SWEDIABKIDS) with all reported newly diagnosed children. Data on C-peptide from the participants in the Better Diabetes Diagnosis study (BDD) from 2007-2010 were used. The definition of partial remission was Insulin Dose Adjusted HbA1c (IDAA1c): HbA1c (%)+(4 x total daily insulin dose (U/kg/day)) ≤9.RESULTS: Of the 3,887 patients, 56% were boys. More boys than girls were in partial remission throughout the follow-up period until 24 months after diabetes onset. Fewer children 0-6 years old had partial remission at 3 and 12 months but not at 24 months compared to older age groups. A larger proportion of patients using CSII at 12 and 24 months remained in partial remission compared to those with MDI (37% vs 33%, p=0.02 and 31% vs 27%, p<0.01 respectively). The level of C-peptide was higher in the group with partial remission and mean HbA1c was lower, both p<0.001. Partial remission at 12 months after diabetes onset was associated with CSII (OR:1.39 CI:1.13, 1.71), shorter diabetes duration (OR:0.80 CI:0.76, 0.84) and male sex (OR:1.23 CI:1.04, 1.46)Conclusions/interpretation: Insulin through MDI, longer duration of diabetes, and female sex were associated with lower frequency of partial remission. Use of CSII seem to contribute to longer partial remission among Swedish children with type 1 diabetes.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Nyckelord
- partial clinical remission
- continuous subcutaneous insulin infusion
- multiple daily injection
- C-peptide
- HbA1c
- partial clinical remission
- continuous subcutaneous insulin infusion
- multiple daily injection
- C-peptide
- HbA1c
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Fureman, Anna-Le ...
-
Bladh, Marie
-
Carlsson, Anneli ...
-
Forsander, Gun, ...
-
Lilja, Mikael
-
Ludvigsson, John ...
-
visa fler...
-
Samuelsson, Ulf
-
Särnblad, Stefan ...
-
Lind, Torbjörn, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Pediatrik
- Artiklar i publikationen
-
Diabetes Technol ...
- Av lärosätet
-
Örebro universitet
-
Umeå universitet
-
Göteborgs universitet
-
Linköpings universitet